Chiasma Inc Asset Turnover Ratio (CHMA), as of first quarter 2021, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Chiasma Inc   (NASDAQ: CHMA)
 

Chiasma Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Chiasma Inc asset turnover ratio, the ability of Chiasma Inc 's assets to generate revenue in the first quarter 2021, increased sequentially to 0.02 in the first quarter (Mar 31 2021), CHMA's balance sheet remain strong.

Within sector Chiasma Inc achieved the highest asset turnover ratio. While asset turnover ranking remained unchanged in the First Quarter 2021 compared to previous quarter at no. .

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CHMA Asset Turnover Ratio (Mar 31 2021)
I. Quarter		 (Dec 31 2020)
IV. Quarter		 (Sep 30 2020)
III. Quarter		 (Jun 30 2020)
II. Quarter		 (Mar 31 2020)
I. Quarter
Y / Y Asset Change 60.88 % 59.14 % 63.58 % 23.28 % 58.8 %
Y / Y Revenue Change - - - - -
Asset Turnover Ratio (TTM) 0.02 0.01 0 - -
CHMA's Total Ranking # # # # #
Seq. Asset Change -11.07 % -10.27 % 134.86 % -14.16 % -12.04 %
Seq. Revenue Change 99.59 % 578.87 % - - -



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #

Asset Turnover Ratio Statistics
High Average Low
0 0 0
 




CHMA Company Profile • Back to CHMA Efficiency Comparisons • Compare CHMA Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Mar 31 2021, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Mar 31 2021 Assets at quarter ending Mar 31 2021
Intra cellular Therapies Inc   0.06 $ 37.608  Millions$ 651.007  Millions
Zymeworks Inc   0.06 $ 31.326  Millions$ 551.752  Millions
Scholar Rock Holding Corp  0.06 $ 15.081  Millions$ 267.168  Millions
Dyadic International Inc   0.06 $ 1.747  Millions$ 30.958  Millions
Oramed Pharmaceuticals Inc  0.05 $ 2.701  Millions$ 49.270  Millions
Fate Therapeutics Inc   0.05 $ 40.061  Millions$ 737.114  Millions
Gyre Therapeutics Inc   0.05 $ 6.049  Millions$ 112.352  Millions
Epizyme Inc.  0.05 $ 22.039  Millions$ 422.356  Millions
Arvinas Inc   0.05 $ 25.200  Millions$ 483.418  Millions
Oncternal Therapeutics Inc   0.05 $ 3.545  Millions$ 68.829  Millions
Chimerix Inc   0.05 $ 5.566  Millions$ 109.637  Millions
Concert Pharmaceuticals Inc   0.05 $ 7.900  Millions$ 156.157  Millions
Pliant Therapeutics Inc   0.05 $ 15.053  Millions$ 302.977  Millions
Meiragtx Holdings Plc  0.05 $ 15.948  Millions$ 321.758  Millions
Endonovo Therapeutics Inc   0.05 $ 0.131  Millions$ 2.689  Millions
One World Products Inc   0.05 $ 0.083  Millions$ 1.798  Millions
Xenetic Biosciences Inc   0.04 $ 0.571  Millions$ 13.175  Millions
Rapt Therapeutics Inc   0.04 $ 5.329  Millions$ 123.385  Millions
Revance Therapeutics Inc   0.04 $ 28.566  Millions$ 671.124  Millions
Shattuck Labs Inc   0.04 $ 9.228  Millions$ 218.916  Millions
Zogenix Inc   0.04 $ 26.078  Millions$ 619.812  Millions
Asensus Surgical Inc   0.04 $ 4.659  Millions$ 114.498  Millions
Cue Biopharma Inc   0.04 $ 3.807  Millions$ 99.056  Millions
Kala Bio inc   0.04 $ 8.557  Millions$ 230.510  Millions
Biocorrx Inc   0.04 $ 0.096  Millions$ 2.653  Millions
Northwest Biotherapeutics Inc  0.04 $ 0.960  Millions$ 26.870  Millions
Alector Inc   0.04 $ 18.037  Millions$ 508.058  Millions
Albireo Pharma inc   0.03 $ 8.725  Millions$ 257.633  Millions
Dbv Technologies S a   0.03 $ 9.497  Millions$ 285.172  Millions
Altimmune inc   0.03 $ 6.979  Millions$ 211.226  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.